147 related articles for article (PubMed ID: 22868899)
1. The antitumor effect of the toll-like receptor 3 ligand polyinosinic-cytidylic acid as an adjuvant.
Huang YK; Zheng Z; Cheng CX; Wang LY; Li YR; Qiu F
Cancer Immunol Immunother; 2013 Feb; 62(2):237-44. PubMed ID: 22868899
[TBL] [Abstract][Full Text] [Related]
2. Polyinosinic-cytidylic acid as an adjuvant on natural killer- and dendritic cell-mediated antitumor activities.
Huang YK; Zheng Z; Qiu F
Tumour Biol; 2013 Jun; 34(3):1615-23. PubMed ID: 23430582
[TBL] [Abstract][Full Text] [Related]
3. Poly I:C enhances cycloheximide-induced apoptosis of tumor cells through TLR3 pathway.
Jiang Q; Wei H; Tian Z
BMC Cancer; 2008 Jan; 8():12. PubMed ID: 18199340
[TBL] [Abstract][Full Text] [Related]
4. Targeting poly(I:C) to the TLR3-independent pathway boosts effector CD8 T cell differentiation through IFN-alpha/beta.
Ngoi SM; Tovey MG; Vella AT
J Immunol; 2008 Dec; 181(11):7670-80. PubMed ID: 19017955
[TBL] [Abstract][Full Text] [Related]
5. Toll-like receptor 3 agonist poly I:C reinforces the potency of cytotoxic chemotherapy via the TLR3-UNC93B1-IFN-β signaling axis in paclitaxel-resistant colon cancer.
Zhao J; Xue Y; Pan Y; Yao A; Wang G; Li D; Wang T; Zhao S; Hou Y
J Cell Physiol; 2019 May; 234(5):7051-7061. PubMed ID: 30387134
[TBL] [Abstract][Full Text] [Related]
6. Toll-like receptor 3 agonist poly(I:C)-induced antiviral response in human corneal epithelial cells.
Kumar A; Zhang J; Yu FS
Immunology; 2006 Jan; 117(1):11-21. PubMed ID: 16423036
[TBL] [Abstract][Full Text] [Related]
7. TLR3: interferon induction by double-stranded RNA including poly(I:C).
Matsumoto M; Seya T
Adv Drug Deliv Rev; 2008 Apr; 60(7):805-12. PubMed ID: 18262679
[TBL] [Abstract][Full Text] [Related]
8. Direct costimulatory effect of TLR3 ligand poly(I:C) on human gamma delta T lymphocytes.
Wesch D; Beetz S; Oberg HH; Marget M; Krengel K; Kabelitz D
J Immunol; 2006 Feb; 176(3):1348-54. PubMed ID: 16424161
[TBL] [Abstract][Full Text] [Related]
9. Surface Toll-like receptor 3 expression in metastatic intestinal epithelial cells induces inflammatory cytokine production and promotes invasiveness.
Bugge M; Bergstrom B; Eide OK; Solli H; Kjønstad IF; Stenvik J; Espevik T; Nilsen NJ
J Biol Chem; 2017 Sep; 292(37):15408-15425. PubMed ID: 28717003
[TBL] [Abstract][Full Text] [Related]
10. The clathrin-mediated endocytic pathway participates in dsRNA-induced IFN-beta production.
Itoh K; Watanabe A; Funami K; Seya T; Matsumoto M
J Immunol; 2008 Oct; 181(8):5522-9. PubMed ID: 18832709
[TBL] [Abstract][Full Text] [Related]
11. Toll-like receptor 3-mediated suppression of TRAMP prostate cancer shows the critical role of type I interferons in tumor immune surveillance.
Chin AI; Miyahira AK; Covarrubias A; Teague J; Guo B; Dempsey PW; Cheng G
Cancer Res; 2010 Apr; 70(7):2595-603. PubMed ID: 20233880
[TBL] [Abstract][Full Text] [Related]
12. Systemic challenge with the TLR3 agonist poly I:C induces amplified IFNalpha/beta and IL-1beta responses in the diseased brain and exacerbates chronic neurodegeneration.
Field R; Campion S; Warren C; Murray C; Cunningham C
Brain Behav Immun; 2010 Aug; 24(6):996-1007. PubMed ID: 20399848
[TBL] [Abstract][Full Text] [Related]
13. β-Glucan-supplemented diets increase poly(I:C)-induced gene expression of Mx, possibly via Tlr3-mediated recognition mechanism in common carp (Cyprinus carpio).
Falco A; Miest JJ; Pionnier N; Pietretti D; Forlenza M; Wiegertjes GF; Hoole D
Fish Shellfish Immunol; 2014 Feb; 36(2):494-502. PubMed ID: 24370748
[TBL] [Abstract][Full Text] [Related]
14. Toll-like receptor 3 activation modulates hippocampal network excitability, via glial production of interferon-β.
Costello DA; Lynch MA
Hippocampus; 2013 Aug; 23(8):696-707. PubMed ID: 23554175
[TBL] [Abstract][Full Text] [Related]
15. Nuclear factor κB subunits RelB and cRel negatively regulate Toll-like receptor 3-mediated β-interferon production via induction of transcriptional repressor protein YY1.
Siednienko J; Maratha A; Yang S; Mitkiewicz M; Miggin SM; Moynagh PN
J Biol Chem; 2011 Dec; 286(52):44750-63. PubMed ID: 22065573
[TBL] [Abstract][Full Text] [Related]
16. Analysis of a TIR-less splice variant of TRIF reveals an unexpected mechanism of TLR3-mediated signaling.
Han KJ; Yang Y; Xu LG; Shu HB
J Biol Chem; 2010 Apr; 285(17):12543-50. PubMed ID: 20200155
[TBL] [Abstract][Full Text] [Related]
17. Urolithin A Inactivation of TLR3/TRIF Signaling to Block the NF-κB/STAT1 Axis Reduces Inflammation and Enhances Antioxidant Defense in Poly(I:C)-Induced RAW264.7 Cells.
Huang WC; Liou CJ; Shen SC; Hu S; Chao JC; Hsiao CY; Wu SJ
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563088
[TBL] [Abstract][Full Text] [Related]
18. The adjuvant effects of the toll-like receptor 3 ligand polyinosinic-cytidylic acid poly (I:C) on antigen-specific CD8+ T cell responses are partially dependent on NK cells with the induction of a beneficial cytokine milieu.
Salem ML; El-Naggar SA; Kadima A; Gillanders WE; Cole DJ
Vaccine; 2006 Jun; 24(24):5119-32. PubMed ID: 16704888
[TBL] [Abstract][Full Text] [Related]
19. Systemic administration of TLR3 agonist induces IL-7 expression and IL-7-dependent CXCR3 ligand production in the lung.
Jin JO; Yu Q
J Leukoc Biol; 2013 Mar; 93(3):413-25. PubMed ID: 23271706
[TBL] [Abstract][Full Text] [Related]
20. Temporally designed treatment of melanoma cells by ATRA and polyI: C results in enhanced chemokine and IFNβ secretion controlled differently by TLR3 and MDA5.
Szabo A; Osman RM; Bacskai I; Kumar BV; Agod Z; Lanyi A; Gogolak P; Rajnavolgyi E
Melanoma Res; 2012 Oct; 22(5):351-61. PubMed ID: 22797253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
